Unity. With respect to each Compound designated as a Development Candidate, Unity shall meet the diligence requirements set forth in the Compound License Agreement for such Development Candidate. In the event that Unity fails to meet such diligence requirements and fails to cure such default in accordance with the terms of such Compound License Agreement, Unity’s right to continue to develop such Development Candidate will terminate, all as further described in such Compound License Agreement.
Appears in 4 contracts
Samples: Restricted Stock Grant Agreement (Unity Biotechnology, Inc.), Compound License Agreement (Unity Biotechnology, Inc.), Compound License Agreement (Unity Biotechnology, Inc.)
